Event Details
This course generates understanding of the range of activities that take a new candidate drug molecule through Development, Manufacturing and Commercialization to routine patient use.
It is a highly interactive, clearly explained journey through:
- Technical development – making the molecule and the medicine
- Preclinical safety – ensuring drugs are safe enough for patient use
- Early clinical trials – evaluating viability of new drugs
- Integrating healthcare with digital support and advanced diagnostics
- Major trials and Regulatory – proving value and seeking license to market
- Branding and commercialization for launch
- Manufacturing and supply chain set up
- Getting new treatments to patients worldwide
Who Should Attend?
Those who will benefit from an understanding of what is done to bring new treatments from the end of the target/drug discovery stage, all the way to patient use. This is helpful (for example) for:
- Scientific and technical staff whose organisations may aspire to build their businesses to later stages of development.
- Service function staff who need to operate better knowing the 'language' of their internal customers.
- BioPharma service companies' staff who need to better understand clients' business.
This course will be delivered on Thursday 29th February 2024 between 09:00-17:00 LIVE in person at the Ark London. Course materials are included in the course costs.
